@article{28809,
  keywords = {Mass drug administration, Lymphatic filariasis, Diethylcarbamazine citrate, Coverage},
  author = {Tirkey L and Sengupta D and Naskar S and Ghosh S and Hoque N and Goswami M and Mandal NK},
  title = {Assessing coverage and compliance of mass drug administration under Elimination of Lymphatic Filariasis Program in Malda District, West Bengal.},
  abstract = {<p><strong>Background:</strong> Lymphatic filariasis, commonly known as elephantiasis, is a neglected tropical disease. Evaluation of mass drug administration (MDA) is done internally by the health authorities and externally by independent agencies. This paper reports the findings of evaluation of MDA conducted in Malda district of West Bengal state in May-June 2015. <strong>Objectives:</strong> To assess the Coverage &amp; Compliance rates of MDA against lymphatic filariasis and to study the factors influencing non-coverage and non-compliance in Malda district. <strong>Materials &amp; Methods:</strong> A Community based cross-sectional study was conducted in three selected rural blocks and one municipality. Family was the unit of sampling in the current MDA coverage survey. 30 families in each of four clusters were taken as samples. Cluster sampling technique was adopted. The data was collected in a pre-designed semi-structured proforma from 120 households.<strong> Results: </strong>564 eligible population 120 families were studied and 50.53% of them were males. Predominant respondents were male (92%) with average age 40.7 years. The Diethylcarbamazine citrate plus Albendazole coverage rate was 95% and the compliance rate was 71.6%. The major reason for non–compliance was due to fear of side effects amounting to 58%. Only 4 persons reported adverse effects after drug consumption. <strong>Conclusion:</strong> Though distribution was high, many people were not consuming drugs. Consumption was not properly supervised and there was misconception prevailed among workers about time of consumption. A high level of motivation and commitment from the drug distributors with adequate training is required for ensuring a high coverage and compliance rates. Supervision should be strengthened to improve consumption and misconception should be eliminated through training.&nbsp;&nbsp;</p>
},
  year = {2016},
  journal = {Journal of Comprehensive Health},
  volume = {4},
  pages = {49-56},
  url = {http://www.journalofcomprehensivehealth.co.in/current%20issue/july2016/PDF/orginalarticle3.pdf},
  language = {eng},
}